Day 1 – 24 September 2022 | Day 2 – 25 September 2022
Sunday, 25 September 2022
DAY 2: INTRODUCTION
Welcome Note for Day 2
Rose Dlamini (WHO WR Ethiopia)
SESSION 5: ADVOCACY, COMMUNICATION, AND SOCIAL MOBILIZATION AMONG HEALTH WORKFORCE FOR HPV VACCINATION
Chairs: Sabrina Kitaka (Makerere University, Uganda) & Zoey Diaz (BMGF)
HPV communication plan: crisis management plan, needs and lessons learnt/ Plan de communication HPV: Gestion des crises et leçons apprises (Le cas du Sénégal)
Mrs. Raabi Diouf (UNICEF, Senegal)
Communication for health work force at the district level: approaches and challenges
HPV Communication for healthcare workers at facility level: Approaches and challenges
Rosemary Njura Njogu (Jhpiego, Kenya)
Social Mobilization and advocacy in Sebeta, Ethiopia
Mrs. Belaynesh Mekonnen (Healthcare professional, Ethiopia)
SESSION 6A: TRAINING AND SENSITIZATION OF STAKEHOLDERS INVOLVED IN DECISION-MAKING, PLANNING AND IMPLEMENTATION
Chairs: Dr. Mutale Mumba (WHO) & Mengistu Bogale (EPI, MOH Ethiopia)
Training and Sensitization: A critical aspect of a vaccination program and implication on HPV vaccination programs
Mengistu Bogale (EPI, MOH Ethiopia)
SESSION 6B: TRAINING OF HEALTH WORKFORCE (VACCINATORS/HEALTHCARE PROFESSIONALS/ FRONT LINE WORKERS
Chairs: Dr. Mutale Mumba (WHO) & Dur-e-Nayab Waheed (University of Antwerp)
Training of healthcare professionals(HCP) at the district level; challenges and gaps
Thomas Lweya (EPI coordinator for Ntchisi district, Malawi)
Optimizing training approaches: considerations for program implementers
Joseph Rujumba (Makerere University, Uganda)
SESSION 7: SUSTAINABILITY AND RESTORING HPV VACCINATION PROGRAMS
Chairs: Cathy Ndiaye (PATH) & Christopher Morgan (Jhpiego)
HPV vaccine delivery strategy in Tanzania – Towards sustainable delivery platforms and coverage
Dr. Florian Tinuga ( EPI, MOH, Tanzania)
HPV Vaccine Delivery Strategy: How to move forward sustainable delivery platform and facilitators to achieve sustainable coverage.
Dr. Meseret Zelalem (MCHND Director, Federal Ministry of Health Ethiopia)
Intensifying immunization of girls aged 9-14 years as a mitigation strategy for COVID- 19 on HPV Vaccination: Experience in Côte d’Ivoire/ Intensification de la vaccination des filles de 9-14 ans comme stratégie d’atténuation des effets de la COVID-19sur la vaccination contre le HPV : Expérience de la Côte d’Ivoire
Kouakou Seraphin (Jhpiego, Cote d’Ivoire)
Opportunities for integrating HPV vaccination program with adolescent health services
Clarence Mbanga (CHAI, Cameroon)
SESSION 8: CERVICAL CANCER ELIMINATION PARTNERS LANDSCAPE AND THEIR ACTIVITIES
Chairs: Dr. Vellepi Mtonga & Dr. Yirgu Gebrehiwot
Public Health Initiative Liberia
Ms. Joyce L. Kilikpo Jarwolo
DREAMS project Malawi
Ms. Getrude Chipungo
UICC’s Role in Cervical Cancer Elimination
Her Excellency Dr Zainab Shinkafi Bagudu
The African Cancer Registry Network
Ms. Ann Korir
The Kebbi integrated approach PHC revival and cancer control.
Dr. Abubakar Dan Kaoje
SESSION 9: BREAKOUT GROUPS
Chairs: University of Antwerp Team
Breakout group 1: Professional associations and their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
Breakout group 2: NGOs and Implementers and their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
Breakout group 3: MOH & Global partners – their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
Plenary feedback per group in the main session.
SESSION 10: CONCLUSIONS
Chairs: Prof. Dr. Mathuram Santosham (John Hopkins University) & Prof. Dr. Alex Vorsters (University of Antwerp)